As exemplified by NRF2’s dual role as both a potential tumor suppressor and oncogenic protein in various cancers46, the degree to which a particular aging- or disease-related TF is activated or inhibited, in addition to often observed tissue- and context-dependency of effects, needs to be considered when designing appropriate interventions. Here, NFE2L2 is linked to neoplasm.